TSC2 mediates cellular energy response to control cell growth and survival.
By K. Inoki, Tianqing Zhu, K. Guan. Cell, 2003
3,956 citations recorded by the source corpus.
Mutations in either the TSC1 or TSC2 tumor suppressor gene are responsible for Tuberous Sclerosis Complex. The gene products of TSC1 and TSC2 form a functional complex and inhibit the phosphorylation of S6K and 4EBP1, two key regulators of translation. Here, we describe that TSC2 is regulated by cellular energy levels and plays an essential role in the cellular energy response pathway. Under energy starvation conditions, the AMP-activated protein kinase (AMPK) phosphorylates TSC2 and enhances its activity. Phosphorylation of TSC2 by AMPK is required for translation regulation and cell size control in response to energy deprivation. Furthermore, TSC2 and its phosphorylation by AMPK protect cells from energy deprivation-induced apoptosis. These observations demonstrate a model where TSC2 functions as a key player in regulation of the common mTOR pathway of protein synthesis, cell growth, and viability in response to cellular energy levels.
Subfields: Cell Biology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/5b6d80dcd56730ba0aaa0681f860dd965e81cbca
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cell Biology
- David M. Sabatini
- D. Hardie
- K. Guan
- R. Shaw
- Michael N. Hall
- M. Laplante
- D. Klionsky
- Asier González González
In Molecular Biology
Citations in the corpus
- Upstream and downstream of mTOR. (2004, background): “Some studies show that the expression of both TSC2 and TSC1 is required for efficient GAP activity (Garami et al. 2003; Tee et al. 2003b; Zhang et al. 2003b), whereas others show that TSC2 alone is sufficient (Castro et al. 2003; Inoki et al. 2003a).”
- Dysregulation of the TSC-mTOR pathway in human disease (2004, background): “In the mechanism proposed to account for this phenomenon, the 5′ AMP-activated protein kinase (AMPK) phosphorylates and activates TSC2, thereby inhibiting mTOR activation in response to changes in the intracellular ATP/AMP rati”
- ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS (2010, background): “performed as previously described (9).”
- AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy (2007, background): “AMPK phosphorylates the TSC1–TSC2 complex and appears to enhance its ability to switch off TO”
- Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. (2004, background): “Pharmacological inhibition of AMPK with compound C (Inoki et al. 2003b) at doses sufficient to block the down-regulation of S6 phosphorylation by AICAR did not block the down-regulation of S6 phosphorylation by hypoxia (Fig.”
- Regulation of mTORC1 by amino acids (2014, neutral): “The TSC complex, whose loss underlies a hamartomatous syndrome of the same name (17, 18), serves as a central hub for numerous extracellular and intracellular inputs including mitogen and growth factor signaling (19-23), energy levels (24), oxygen availability (25, 26) and genotoxic stress (27), whi”
- Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. (2004, background): “Our previous studies have established that TSC2 acts directly downstream of AMPK in the cellular energy response pathway, as AMPK directly phosphorylates TSC2 on S1227 and S1345 in response to low energy conditions (Inoki et al. 2003).”
- PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. (2007, background): “For example, energy deprivation sensed by AMPK (Inoki et al., 2003b), MAPK signaling lar Cell 25, 903–915, March 23, 2007 ª2007 Elsevier Inc. 903 (Ma et al., 2005; Roux et al., 2004; Tee et al., 2003a), and hypoxia and stress sensing (Brugarolas et al., 2004; Corradetti et al., 2005; Reiling and Haf”
- Defining the role of mTOR in cancer. (2007, background): “Consistent with this idea, tsc2-deficient cells undergo apoptosis in glucose-free medium, a response suppressed by rapamycin (Inoki et al., 2003).”
- The LKB1 tumor suppressor negatively regulates mTOR signaling. (2004, methodology): “Notably, Tsc2 / MEFs were recently found to undergo apoptosis under conditions of glucose deprivation, which also serves to activate AMPK (Inoki et al., 2003).”